Five Stocks to Watch

Five Stocks to Watch

Jessica Amir
Market Strategist

Summary:  Watch our three minute video covering five stocks to watch this week. In no particular order stocks to watch include Dexcom which has become the best-performing stock in the S&P500 this month after announcing its newest glucose wearable device is available globally. Marathon Oil is another to watch which has been rallying after OPEC+ production cuts were announced. Plus what to watch when it comes to JPMorganChase’s results. And why to also keep Rivian and Fortescue Metals on your radar

Here are five stocks to perhaps watch in no particular order 



Dexcom (DXCM)

Dexcom is so far the best performing stock in the S&P500 this month up 24% after announcing its newest glucose wearable device, Dexcom G7 is available globally, to those with diabetes aged 2 years and over. The wearable device is now selling in the UK, Ireland, Germany, Austria, and Hong Kong, with launches to take place soon in New Zealand and South Africa. 

Marathon Oil (MRO)

Marathon Oil is also one of the best performers in the S&P500 so far this month, up 20%. Marathon Oil along with many oil and gas producers have been rallying this month following the Oil price (West Texas Intermediate) moving up 16% in 11 days. It comes as OPEC+ agreed to reduce oil output by 2 million barrels a day from November. So the market is once again dealing with supply fears in the oil market. 

 

JPMorganChase (JPM)

JPMorgan is the 14th biggest US stock among the S&500. It’s due to report third-quarter financial quarter results in the second week of October along with Morgan Stanley (MS) and Citigroup (C). The two key things to watch with banks are their net interest margin and if that’s improving or weakening. Secondly, keep an eye on the quality of the banks' loan books - and if they’ve deteriorated or improved. 

 

Rivian (RIVN)

Rivian announced the EV maker is recalling 13,000 vehicles it delivered to customers, that’s nearly all the vehicles it sold. It comes as the company found a minor structural defect. Even though Rivian says the issue was discovered in seven vehicles, it recalled all out of caution 

Fortescue Metals (FMG)

Fortescue Future Industries, teamed up with fellow ASX-listed company Incitec Pivot (IPL) to convert IPL’s ammonia facility into a hydrogen electrolysis hub. A Final Investment Decision is not expected to be made until 2023. However, its hoped the hub will produce green ammonia, which can be exported, used in fertilizer, or used as a low-carbon fuel source for heavy transport, airports, and ports. 


To find out more head to Saxo. 
Type in the Stock you want. And click on the Overview page for fundamental analysis. 



-


For a global look at markets – tune into our Podcast.



 

Disclaimer

The Saxo Group entities each provide execution-only service, and access to analysis permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Inspiration Disclaimer and (v) Notices applying to Trade Inspiration, Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular, no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
Full disclaimer (https://www.home.saxo/en-sg/legal/disclaimer/saxo-disclaimer)

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments. Saxo Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Markets or its affiliates.

Saxo Markets
88 Market Street
CapitaSpring #31-01
Singapore 048948

Contact Saxo

Select region

Singapore
Singapore

Saxo Capital Markets Pte Ltd ('Saxo Markets') is a company authorised and regulated by the Monetary Authority of Singapore (MAS) [Co. Reg. No.: 200601141M ] and is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms & Risk Warning to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products such as Margin FX products may result in your losses exceeding your initial deposits. Saxo Markets does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Markets does not take into account an individual’s needs, objectives or financial situation.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-sg/about-us/awards.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website are not intended for residents of the United States, Malaysia and Japan. Please click here to view our full disclaimer.

This advertisement has not been reviewed by the Monetary Authority of Singapore.

Apple and the Apple logo are trademarks of Apple Inc, registered in the US and other countries and regions. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC.